期刊文献+

小剂量喹硫平与坦度螺酮治疗广泛性焦虑障碍的对照研究 被引量:3

下载PDF
导出
摘要 目的比较小剂量(100~200mg)喹硫平与坦度螺酮治疗广泛性焦虑障碍的疗效和副反应。方法将60例符合CCMD-3广泛性焦虑障碍诊断标准的患者随机分为小剂量喹硫平组30例和坦度螺酮组30例,疗程8周,用汉密尔顿焦虑量表(HA-MA)和不良反应症状量表(TESS)评定疗效和副反应。结果在治疗的第1周、第2周末小剂量喹硫平组的HAMA分值均低于坦度螺酮组,而在第4、6、8周末,两组患者的HAMA分值比较差异无统计学意义(P>0.05)。在治疗的第8周末时,小剂量喹硫平组组的治愈率为66.6%,有效率为86.7%;坦度螺酮组分别为63.3%,90.0%,两组比较差异无统计学意义(P>0.05)。在不良反应方面,两组比较差异无统计学意义(P>0.05)。结论小剂量喹硫平与坦度螺酮治疗广泛性焦虑障碍的疗效相但当,不量反应无明显差异。
出处 《中外医学研究》 2011年第29期55-56,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
  • 相关文献

参考文献4

二级参考文献25

  • 1陈良珠,文若兰,廖少玲.胃癌患者围手术期抑郁焦虑影响因素分析[J].国外医学(护理学分册),2005,24(4):182-185. 被引量:25
  • 2袁瑞,彭勤,廖琼,李红霞.激素替代加抗抑郁剂对更年期综合征患者焦虑、抑郁症状的干预效应(英文)[J].中国临床康复,2006,10(2):162-163. 被引量:11
  • 3张义华,王增珍.恶性肿瘤患者年住院费用研究[J].中国卫生经济,2006,25(12):72-73. 被引量:35
  • 4Dalton SO,Boesen EH,Ross L,et al.Mind and cancer,do psychological factors cause cancer.Eur J Cancer,2009,38(10):1313-1323.
  • 5Tavoli A,Mohagheghi MA,Montazeri A,et al.Anxiety and depression in patients with gastrointestinal cancer:does knowledge of cancer diagnosis matter.BMC Gastroenterol,2010,114(7):28.
  • 6Bodurka-Bevers D,Basen-Engquist K,Carmack CL,et al.Depression,anxiety,and quality of life in patients with epithelial ovarian cancer.Gynecol Oncol,2009,78(3 1):302-308.
  • 7McNeely ML,Campbell KL,Rowe BH,et al.Effects of exercise on breast cancer patients and survivors:a systematic review and meta-analysis.CMAJ,2008,175(1):34-41.
  • 8Surman OS.Possible immunological effects of psychotropic medication.Psychosomatics,2010,34(2):139-143.
  • 9Kessler RC,Berglund P,Demler O,et al.Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.Arch Gen Psychiatry,2005,62:593-602.
  • 10Greenberg PE,Sisitsky T,Kessler RC,et al.The ecomomic burden of anxiety disorders in the 1990s.J Clin Psychiatry,1999,60:427-435.

共引文献3

同被引文献17

  • 1中华医学会精神科分会.中国精神障碍分类与诊断标准第3版[M].济南:山东科学技术出版社,2001.53.
  • 2Mezhebovsky I, Magi K, She F, et al. Double - blind, randomized study of extended release quetiapine fumarate ( quetiapine XR ) monotherapy in older patients with generalized anxiety disorder [J]. Int J Geriatr Psychiatry,2013,28(6) :615 -625.
  • 3Katzman MA, Vemani M, Jacobs L, et al. Quetiapine as an adju- netive phan acotherapy for the treatment of non - remitting general- ized anxiety disorder a flexible - dose, open - labled pilot trail [ J]. Axiety disord, 2008,22( 8 ) :ldS0 - 1486.
  • 4Mezhebovsky I,Magi K,She F,et a1. Double-blind,randomized study of extended releae quetiapine fumarate(quetiapine XR)monotherapy in older patients with generalized anxiety disorder. Int J Geriatr Psychiatry,2013;28(6):615-625.
  • 5沈鱼屯.精神病学.第5版.北京:人民卫生出版社,2009:882.
  • 6Davidson JR,Feltner DE,Dugar A. Management of generalized anxiety disorder in primary care:identifying the challenges and unmet needs. Prim Care Companion J Clin Psychiatry,2010;12(2):205-210.
  • 7李长安,张凤林,方向明,傅文农,施和勋,何苏民,骆加文,张惠芳,张媛媛.小剂量喹硫平治疗广泛性焦虑临床对照研究[J].上海精神医学,2009,21(5):293-293. 被引量:10
  • 8李一云,黄梅华.帕罗西汀联合小剂量富马酸喹硫平治疗焦虑障碍的临床分析[J].中华行为医学与脑科学杂志,2010,19(4):348-349. 被引量:6
  • 9张虹,梁宏光,雍生满.米氮平合并小剂量喹硫平治疗广泛焦虑症对照研究[J].医学信息(下旬刊),2010,23(10):54-55. 被引量:2
  • 10王继辉,吴小立,魏钦令,韩自力.广泛性焦虑症患者苯二氮卓类药物使用情况及与首诊处方的关系[J].中华行为医学与脑科学杂志,2011,20(8):701-703. 被引量:16

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部